Goch, Germany (7th December 2021) – DFE Pharma Product Application Specialist, Alberto Berardi, has been recognized as one of the 2021 Outstanding Early Career Scientists by the editors of the Journal of Pharmaceutical Sciences and the American Pharmacists Association1. These awards acknowledged outstanding early career scientists for publishing their most original and significant scientific findings.
Berardi’s recognition came from his article which focused on superdisintegrants. These are often not interchangeable within a formulation and thus appropriate selection is key for effective disintegration performance. Specifically, he showed in the study that in a hydrophobic matrix tablet formulation, croscarmellose sodium and sodium starch glycolate could still provide rapid disintegration upon harsh storage conditions, while crospovidone could not. The study was recognized by the JPharmSci® editors as one of the six-monthly featured articles in the May issue.
“I am very proud of this recognition received by our colleague Alberto Berardi. His award is a great example of how at DFE Pharma we strive to offer, not only premium quality excipients, but also expert services and key insights to our customers” comments Bas van Driel, CEO of DFE Pharma, “Together with our portfolio, our expertise and knowledge base enables us to support (bio)pharmaceutical companies in their success towards a healthier world”.
Berardi holds a master’s degree in Pharmacy from the University of Camerino (Italy) and a PhD in Pharmaceutical Technology from the University of East Anglia (UK). Before joining DFE Pharma, he worked in academia as associate professor in pharmaceutical technology in Jordan. Berardi has 28 scientific publications in journals in the field of pharmaceutical technology and drug delivery. His area of expertise is on Oral Solid Dose (OSD) with particular focus on superdisintegrants and he is now a Product Application Specialist in OSD at DFE Pharma.
These awards recognize scientists who were the primary authors of articles and were either graduate students or within their first 10 years post-Ph.D. in a permanent appointment (such as an academic, foundation, government, or industrial scientist position) to bring further attention to their scientific research and achievements.
1) Journal of Pharmaceutical Sciences. 2021 Outstanding Early Career Scientists